Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label Safety and Tolerability Trial of CPP-109 (Vigabatrin) in Adults With Treatment Refractory Tourette's Disorder

NCT01585207 is registered in ClinicalTrials.gov with Barbara J. Coffey as lead sponsor.

NCT NCT01585207
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01585207 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label Safety and Tolerability Trial of CPP-109 (Vigabatrin) in Adults With Treatment Refractory Tourette's Disorder
Lead sponsor
Barbara J. Coffey
Phase
Phase 1/2
Overall status
Completed
Start date
July 31, 2012
Completion date
March 31, 2015
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tourette's disorder